Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
60 participants
INTERVENTIONAL
2011-06-30
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Speech Perception for Children With Cochlear Implants
NCT01059838
Cochlear Implant Speech in Noise Processing
NCT06860152
Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants
NCT05810220
Optimizing Bilateral and Single-sided-deafness Cochlear Implants for Functioning in Complex Auditory Environments
NCT06305039
Perceptual Consequences of Cochlear Implant Electrode-neuron Interfaces
NCT05867173
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ciPDA
ciPDA
The ciPDA Research Platform device was designed as a research tool for cochlear implant research.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ciPDA
The ciPDA Research Platform device was designed as a research tool for cochlear implant research.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years of age or older
* Unilateral or bilateral Nucleus implant users (this includes all three generations of the Nucleus system, i.e., CI22, CI24 and CI24R).
* With or without residual hearing in the contralateral ear. Subjects may use amplification (hearing aid) in the opposite or same ear as the implant.
* A minimum test score of 30% in tape-recorded open-set sentence recognition scores (e.g., spondee identification).
* Minimum of 6 months experience with their implant device. This is done to ensure that all patients are familiar with the hearing sensations perceived by a cochlear implant.
* Minimum number of active electrodes: 10
* Minimum number of subjects for each test site: 5
2. Prelingually and perilingually deafened adults:
* 18 years of age or older
* Unilateral or bilateral Nucleus implant users.
* With or without residual hearing in the contralateral ear. Subjects may use amplification (hearing aid) in the opposite or same ear as the implant.
* A minimum test score of 10% in tape-recorded open-set sentence recognition scores (e.g., spondee identification).
* Minimum of 6 months experience with their implant device. This is done to ensure that all patients are familiar with the hearing sensations perceived by a cochlear implant.
* Minimum number of active electrodes: 10
* Minimum number of subjects for each test site: 5
Exclusion Criteria
* Hearing loss of neural or central origin
* Absence of cochlear or VIII nerve development
* The presence of systemic condition which would preclude use of a cochlear implant
* Active middle ear infection/tympanic membrane perforation
* Significantly abnormal cognitive function, as determined by case history information and/or clinical observations
* Significant psychiatric disorder, as determined by case history information and/or clinical observations
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Philip Loizou
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Philip Loizou
PI
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philip Loizou, PhD
Role: PRINCIPAL_INVESTIGATOR
The University of Texas at Dallas
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Texas - Dallas
Richardson, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ciPDA0001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.